Literature DB >> 7743746

Peripheral blood lymphocyte subsets in polymyalgia rheumatica.

A Uddhammar1, G Roos, B Näsman, S R Dahlqvist.   

Abstract

Peripheral blood lymphocytes from 23 patients with polymyalgia rheumatica (PMR) were characterized using monoclonal antibodies and flow cytometry in a two-year prospective study. There were no significant differences in absolute numbers or relative percentages of lymphocytes or CD3+, CD4+, CD8+ T cells or the CD4+ T cell functional subsets, virgin (CD4+CD45RA+) and memory (CD4+CD29+) T cells, in patients before or during corticosteroid treatment compared to controls. Previous reports on decreased levels of CD8+ T cells as a characteristic of PMR/giant cell arteritis was not confirmed. The absolute number and relative percentage of lymphocytes with natural killer cell activity, CD16+ CD56+ cells, were significantly lower in patients with active untreated PMR as well as during corticosteroid treatment compared to controls, but at the two-year follow-up the difference was less marked.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743746     DOI: 10.1007/BF02208086

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

1.  Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies.

Authors:  A Kahan; K Hamzaoui; K Ayed
Journal:  J Rheumatol       Date:  1992-05       Impact factor: 4.666

Review 2.  Biology and clinical relevance of human natural killer cells.

Authors:  M J Robertson; J Ritz
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

3.  Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  B Dasgupta; O Duke; A M Timms; C Pitzalis; G S Panayi
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

Review 4.  VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

Authors:  M E Hemler
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment.

Authors:  M C Cid; E Campo; G Ercilla; A Palacin; J Vilaseca; J Villalta; M Ingelmo
Journal:  Arthritis Rheum       Date:  1989-07

6.  Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases.

Authors:  C Morimoto; P L Romain; D A Fox; P Anderson; M DiMaggio; H Levine; S F Schlossman
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

7.  The isolation and characterization of the human helper inducer T cell subset.

Authors:  C Morimoto; N L Letvin; A W Boyd; M Hagan; H M Brown; M M Kornacki; S F Schlossman
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

8.  Abnormalities of peripheral blood T lymphocyte subsets in polymyalgia rheumatica.

Authors:  G Chelazzi; M Broggini
Journal:  Clin Exp Rheumatol       Date:  1984 Oct-Dec       Impact factor: 4.473

9.  HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis.

Authors:  R Andersson; G K Hansson; T Söderström; R Jonsson; B A Bengtsson; E Nordborg
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

10.  Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus.

Authors:  W L Sibbitt; P M Mathews; A D Bankhurst
Journal:  Arthritis Rheum       Date:  1984-10
View more
  2 in total

Review 1.  CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors?

Authors:  Rosanne D Reitsema; Annemieke M H Boots; Kornelis S M van der Geest; Maria Sandovici; Peter Heeringa; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

2.  Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Yannick van Sleen; Jacoba C Graver; Wayel H Abdulahad; Kornelis S M van der Geest; Annemieke M H Boots; Maria Sandovici; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.